Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20063537HPVENSG00000165060.15protein_codingFXNNoNo2395A0A0S2Z3G4
Q16595
TVIS20063538HPVENSG00000165060.15protein_codingFXNNoNo2395A0A0S2Z3G4
Q16595
TVIS20065995HPVENSG00000165060.15protein_codingFXNNoNo2395A0A0S2Z3G4
Q16595
TVIS20063930HPVENSG00000165060.15protein_codingFXNNoNo2395A0A0S2Z3G4
Q16595
TCGA Plot Options
Drug Information
GeneFXN
DrugBank IDDB01592
Drug NameIron
Target IDBE0008991
UniProt IDQ16595
Regulation Type
PubMed IDs16911956
CitationsBencze KZ, Kondapalli KC, Cook JD, McMahon S, Millan-Pacheco C, Pastor N, Stemmler TL: The structure and function of frataxin. Crit Rev Biochem Mol Biol. 2006 Sep-Oct;41(5):269-91.
GroupsApproved
Direct ClassificationHomogeneous transition metal compounds
SMILES[Fe]
PathwaysCerivastatin Action Pathway; Oxidation of Branched-Chain Fatty Acids; Simvastatin Action Pathway; Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2); Galactosemia III; Smith-Lemli-Opitz Syndrome (SLOS); Tyrosine Metabolism; Zellweger Syndrome; Hereditary Coproporphyria (HCP); Hypercholesterolemia; Glucose-6-phosphate Dehydrogenase Deficiency; Mevalonic Aciduria; Porphyrin Metabolism; Tryptophan Metabolism; Taurine and Hypotaurine Metabolism; Pentose Phosphate Pathway; Inositol Metabolism; Catecholamine Biosynthesis; Phenylketonuria; Vitamin A Deficiency; Congenital Erythropoietic Porphyria (CEP) or Gunther Disease; Cystinosis, Ocular Nonnephropathic; Pyrimidine Metabolism; Congenital Disorder of Glycosylation CDG-IId; Lovastatin Action Pathway; Nucleotide Sugars Metabolism; Aromatic L-Aminoacid Decarboxylase Deficiency; Cysteine Metabolism; Galactose Metabolism; The Oncogenic Action of Fumarate
PharmGKBPA450087
ChEMBL